Pure Global

ARCHITECT Anti-TPO Reagent - India CDSCO Medical Device Registration

ARCHITECT Anti-TPO Reagent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000419_e7c52bfc855016c695b1c6aeb8f0fe6c_e454dffd33576ddab8481819a5c16b95. This device is marketed under the brand name DILUENT/SHEATH. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
ARCHITECT Anti-TPO Reagent
UID: IMP/IVD/2019/000419_e7c52bfc855016c695b1c6aeb8f0fe6c_e454dffd33576ddab8481819a5c16b95

Brand Name

DILUENT/SHEATH

Device Class

Class B

Approving Authority

CDSCO

Product Information

ARCHITECT Anti-TPO is a Chemiluminescent Microparticle Immunoassay (DILUENT/SHEATH) for the quantitative determination of the IgG class of thyroid peroxidase autoantibodies (DILUENT/SHEATH) in human serum and plasma on the ARCHITECT iSystem. The ARCHITECT Anti-TPO assay is intended for use as an aid in the diagnosis of thyroid disease

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing